ClinVar Miner

Submissions for variant NM_001365276.2(TNXB):c.2170C>T (p.Arg724Cys)

gnomAD frequency: 0.00114  dbSNP: rs138771398
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genomic Research Center, Shahid Beheshti University of Medical Sciences RCV000785001 SCV000923551 uncertain significance Ehlers-Danlos syndrome due to tenascin-X deficiency 2019-01-01 criteria provided, single submitter clinical testing
GeneDx RCV001662817 SCV001874227 uncertain significance not provided 2023-05-01 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV002279528 SCV002566224 likely benign Ehlers-Danlos syndrome 2021-04-05 criteria provided, single submitter clinical testing
Ambry Genetics RCV002424780 SCV002730538 likely benign Cardiovascular phenotype 2024-03-12 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV002493432 SCV002803892 uncertain significance Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 2022-05-02 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001662817 SCV002821365 likely benign not provided 2024-06-01 criteria provided, single submitter clinical testing TNXB: BP4
PreventionGenetics, part of Exact Sciences RCV003928271 SCV004746015 likely benign TNXB-related disorder 2022-12-22 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Breakthrough Genomics, Breakthrough Genomics RCV001662817 SCV005188883 uncertain significance not provided criteria provided, single submitter not provided
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV001662817 SCV001977737 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV001662817 SCV001978399 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.